Post on 05-Jun-2018
Conference Secretariat5716 Corsa Ave., Suite 110, West Lake, Los Angeles, CA 91362-7354, USA
Ph: +1-702-508-5200, Fax: +1-650-618-1414, Toll free: +1-800-216-6499Email: clinicaltrials@conferenceseries.net
Tentative Programe
http://clinicaltrials.conferenceseries.com/
Theme: An Insight into Innovative Approaches in Global Clinical Research and Clinical Trials
250+ Participation (70% Industry:30% Academia) includes
12+ Interactive Sessions 50+ Plenary
Lectures5+ Keynote Lectures
20+ Exhibitors B2B Meetings
5+ Workshops
Clinical TrialsSan Antonio, USA September 11-13, 2017
4th International Conference on
conferenceseries.com
http://clinicaltrials.conferenceseries.com/
Reception/Registration Time
09.00-09.1509.15-09.4509.45-10.1510.15-10.45
Time Session 1 Session 2
5 Speakers (20 Mins Each) 5 Speakers (20 Mins Each)
5 Speakers (20 Mins Each) 5 Speakers (20 Mins Each)
5 Speakers (20 Mins Each) 5 Speakers (20 Mins Each)
5 Speakers (20 Mins Each) 5 Speakers (20 Mins Each)
Time Session 1 Session 209.00-10.40 5 Speakers (20 Mins Each) 5 Speakers (20 Mins Each)
10.55-12.35 5 Speakers (20 Mins Each) 5 Speakers (20 Mins Each)
13.25-15.05 5 Speakers (20 Mins Each) 5 Speakers (20 Mins Each)
15.20-17.00 5 Speakers (20 Mins Each) 5 Speakers (20 Mins Each)
40 S
peak
ers o
n Da
y 2
Even
ing
Sess
io
Least of 3 Keynote/Plenary Talks
For more Details PS: www.clinicaltrials.conferenceseries.com
clinicaltrials@conferenceseries.net | clinicaltrials@conferenceseries.com
NOTE: Program Schedule is subject to change with final allotment of the speaker slots
Day 2
Panel Discussions/Group Photo
Coffee/Tea Break 15.30-15.45 (Networking)
Lunch Break 12.40-13.30
Coffee/Tea Break 10.45-11.00 (Networking)
Mor
ning
Ses
sion
sEv
enin
g Se
ssio
ns
19 S
peak
ers f
or D
ay 1
4th International Conference on
Clinical TrialsSeptember 11-13, 2017 San Antonio, USA
08.00-09.00
Poster Sessions
11.00-12.40
13.30-15.30
09.00-10.40
10.55-12.35
13.25-15.05
15.45-17.25
Lunch Break 12.35-13.25
General Session
Program at a Glance
5 Speakers (20 Mins Each)
Day 1
Coffee/Tea Break 15.05-15.20 (Networking)15.20-17.00
Coffee/Tea Break 10.40-10.55 (Networking)
Coffee/Tea Break 15.05-15.20 (Networking)
Mor
ning
Ses
sion
s
40 S
peak
ers o
n Da
y 3
Even
ing
Sess
ions
Inaugural AddressKeynote/Plenary Talk 1Keynote/Plenary Talk 2Keynote/Plenary Talk 3
6 Speakers (20 Mins Each)
Coffee/Tea Break 10.40-10.55 (Networking)
5 Speakers (20 Mins Each)
Mor
ning
Ses
sion
s
Closing Ceremony
Poster Sessions
Lunch Break 12.35-13.25
Day 3
Conference Highlights• Drug Discovery and Development
• Preclinical Research
• Clinical Study Designs
• Conducts of Clinical Trials
• Patient-Centric Clinical Trials
• Research and Trials on AIDS / Cancer / Diabetes
• Clinical Trials on different Diseases
• Clinical Data Management and Statistics
• Globalization of Clinical Trials
• Innovations in Clinical Trials
• Future of Clinical Trials
• CRO/Sponsorship Clinical Trials
• Clinical Trial Site Management and Business Development
• Outsourcing in Clinical Trials
• Bioethics and Quality Regulation
• Medical and Clinical Case Reports
• Pharmacovigilance and Drug Safety
http://clinicaltrials.conferenceseries.com/
Glimpses of Clinical Trials Conferences
http://clinicaltrials.conferenceseries.com/
Glimpses of Clinical Trials 2016
http://clinicaltrials.conferenceseries.com/
TOURIST DESTINATIONS IN SAN ANTONIO
National Historical Park Riverwalk
Museum of Art
Morgan’s Wonderland
Botanical Garden
Tower of the Americas
Natural Bridge Caverns
Alamo Treasurehttp://clinicaltrials.conferenceseries.com/
Contact usAmerica: Conference Series LLC
Clinical Trials 20172360 Corporate Circle., Suite 400 Henderson,
NV 89074-7722, USAPhone: +1-888-843-8169, Fax: +1-650-618-1417
Toll free: +1-800-216-6499Email: clinicaltrials@conferenceseries.net
Contact us Asia-Pacific: Conference Series
Clinical Trials 2017Divyasree Building, Raidurg
6th Floor, North Block Hyderabad 500032, INDIA
Tel: 040-33432334Email: clinicaltrials@conferenceseries.net
Contact us UK: Conference Series Limited
Clinical Trials 2017Heathrow Stockley Park Lakeside House
1 Furzeground WayHeathrow, UB11 1BD, UK
Tel: +1-800-216-6499Email: clinicaltrials@pharmaceuticalconferences.org
http://clinicaltrials.conferenceseries.com/
Conference VenueHilton San Antonio Airport
611 NW Loop 410San Antonio, TX 78216, USA
August 2016 Volume 6, Issue 4ISSN: 2167-0870
Journal of Clinical TrialsOpen Access
631st Conference
conferenceseries.com
Hosting Organizations: Conference Series LLC 2360 Corporate Circle., Suite 400 Henderson, NV 89074-7722, USA
Ph: +1-702-508-5200 Ext: 8028, Fax: +1-650-618-1417, Toll free: +1-800-216-6499
Conference Series LtdHeathrow Stockley Park Lakeside House, 1 Furzeground Way, Heathrow, UB11 1BD, UK, Tel: +1-800-216-6499
Email: clinicaltrials@conferenceseries.net; clinicaltrials@conferenceseries.com
Clinical Trials August 22-24, 2016 Philadelphia, USA
2nd International Conference on
Proceedings of
Supporting Sponsors
300 S. Pierce St. Suite 201 • El Cajon, CA 92020Tel: (619) 334-4764 • Fax: (619) 334-4769
www.triwestresearch.com
est Research Associates
PRECISIONRESEARCH INST ITUTE
Page 9
Day 1 August 22, 2016
Sessions:Pre-Clinical Research | Conducts of Clinical Trials | Clinical Study Designs | Innovations in Clinical Trials| Clinical Data Management and Statistics | CRO/ Sponsorhip and Future of Clinical Trials| Clinical Trial Supply Management
Session Chair: Entsuah Anthony Richard, Merck & Co., Inc., USASession Co-Chair: Suyu Liu, The UT MD Anderson Cancer Center, USA
Session Introduction
Title: Preclinical and clinical research in wound healing and hyperbaric medicineThomas E Serena, SerenaGroup, USATitle: A mixture model using likelihood-based and Bayesian approaches for identifying responders and non-responders in longitudinal clinical trialsEntsuah Anthony Richard, Merck & Co., Inc., USA
Networking and Refreshments @ Foyer
Title: The Burden of Therapy©* [BOTh©*]. A novel method to evaluate the impact of therapeutic agents on patient safetyAyad K Abdul-Ahad, BOTh Analytics GmbH, GermanyTitle: A framework for investigating scientific and medical research misconduct and fraudTamera Norton Smith, Norton Audits, Inc., USATitle: Establishing a standard practice to communicate trial results to study volunteerJill McNair, CISCRP, USATitle: Regulatory and compliance considerations for Direct-To-Patient (DTP) distribution of clinical trial materialMichael Bernstein, Clinical Supplies Management Inc., USATitle: Wound healing characteristics treated by two newly developed amino acid-based biodegradable polymers in burn and incision porcine wound modelsChih-Chang Chu, Cornell University, USA
Lunch Break @ Benjamin’s
Title: Bayesian Decision-Optimal Interval (BOIN) designs for Phase I clinical trialsSuyu Liu, The UT MD Anderson Cancer Center, USATitle: The importance of subject recruitment and retention to clinical trial successJody Ehrhardt, Ehrhardt Clinical Research, USATitle: Good pharma scorecard-A reform strategy to drive improvement clinical trial transparencyJennifer Miller, NYU Langone Medical Center, USATitle: Re-engineering the clinical development processAnvita Karara, Carnegie Mellon University, USA
Opening Ceremonyconferenceseries.com
Keynote ForumIntroductionTitle: Patient centricity – A patient’s perspectiveMichael Bernstein, Clinical Supplies Management Inc., USATitle: Why conferences and continued training really matterJody Ehrhardt, Ehrhardt Clinical Research, USATitle: Phase II clinical trials using formulations of compounds derived from tea plant for restoration of salivary function and treating herpes labialisStephen Hsu, Augusta University, USA
Independence A
Page 10
Workshop
Title: Clinical research site eSource Readiness Assessment tool (eSRA)- A free tool to assist sites in determing if their systems are ready for regulated clinical research dataSuzanne Bishop, North American Facilitator for the eClinical Forum, USA
Networking and Refreshments @ Foyer
Sessions
Title: Low temperature plasmas at atmospheric pressure towards new pharmaceutical products in medicineN Merbahi, University of Toulouse, FranceTitle: High patient satisfaction rating for clinical medication counseling services when provided by clinically trained pharmacistsJoe Martinez, Center Point Clinical Services, USATitle: Functional identification of a CRF-DA microcircuit in mice with relevance to drug abuse Kyle Gobrogge, Tufts University, USATitle: Big data analytics – Clinical integration and visualizationAnkit Lodha, University of Redlands - School of Business, USA
Panel Discussion
Day 2 August 23, 2016
Independence AKeynote Forum
IntroductionTitle: Golden Era of ResearchTamera Norton Smith, Norton Audits, Inc., USATitle: Medical heroes science museum initiative: An innovative approach to patient educationJill McNair, CISCRP, USATitle: The power of translational researchThomas E Serena, SerenaGroup, USA
Networking and Refreshments @ Foyer
Sessions:
Clinical Research and Trials on Diabetes/ AIDS / Cancer | Clinical Trials on Different Diseases and Medical Devices | Clinical Trials (Countries/Continents) | Therapeutic Drug Monitoring and Drug Quantification | Innovations in Clinical Trials
Session Chair: Ayad K Abdul-Ahad, BOTh Analytics GmbH, GermanySession Chair: Joao Paulo Tardivo, Faculdade de Medicina do ABC, Brazil
Session Introduction
Title: Virucidal capacity of novel ProtecTeaV sanitizer formulations containing lipophilic Epigallocatechin-3-Gallate (EGCG)Stephen Hsu, Augusta University, USATitle: Response-Adaptive Randomization urn designs in clinical trialsAnnalisa Piccorelli, University of Wyoming, USATitle: Photodynamic therapy to treat diabetic foot infectionJoao Paulo Tardivo, Faculdade de Medicina do ABC, BrazilTitle: HistoscanningTM for detection of prostate cancer: Does it have any role in routine clinical practice?Saqib Javed, Leighton Hospital NHS Foundation Trust, UK
Workshop
Title: Combating scientific and medical research misconduct and fraudTamera Norton Smith, Norton Audits, Inc., USA
Lunch Break @ Benjamin’s
Page 11
Title: Using Artificial Intelligence to Measure and Optimize Adherence in Clinical TrialsGordon Kessler, AiCure, USATitle: Adverse renal effects of novel molecular oncologic targeted therapies: A review of the FDA Adverse Event Reporting System (FAERS) Rimda Wanchoo, Hofstra Northwell School of Medicine, USATitle: Preliminary in vivo screenning of experimentally induced gastric ulcer of Ledebouria OvatifoliaEugene Jamot Ndebia, Walter Sisulu University, South AfricaTitle: A Modern In-vivo pharmacokinetic (PK) paradigm: Combining snapshot, rapid and full PK approaches to support early drug discoveryChun Li, Genomics Institute of the Novartis Research Foundation, USATitle: Wild leafy vegetable Mormodica foetida, improves metabolic syndrome markers and sperm parameters in diet induced obese male ratsConstance R Sewani-Rusike, Walter Sisulu University, South AfricaTitle: Retrospective analysis of clinical pharmacist medication counseling to improve patient medication compliance and patient retentionJoe Martinez, Center Point Clinical Services, USATitle: SharePoint development and implementation in a tertiary care center in LebanonUlfat Usta Shanouha, American University of Beirut Medical Center, Lebanon
Networking and Refreshments @ Foyer
Title: Reflection of knowledge and concern of ethical principles among biomedical postgraduates: A cross sectional observational study from IndiaKrishnan Vengada ragava Chary, Saveetha University, India
Poster Presentations @ Foyer
CLTRS001Title: Magnitude and characteristics of clinical trials in Saudi Arabia: A cross-sectional analysis
Sheraz Ali, King Saud Medical City, KSA
CLTRS002Title: Monitoring long term plasma Ochratoxin A levels of female rats: Fluctuating OTA levels and toxicodynamics
Mehmet Akif Kilic, Akdeniz University, Turkey
CLTRS003Title: Assessment of awareness about ethics committee amongst the research scholars/teachers in government medical colleges of punjab, India
Ramandeep Kaur Brar, Baba Farid University of Health Sciences, India
CLTRS004Title: Emerging role of bioinformatics tools and softwares in evolution of clinical research
Supreet Kaur Gill, Baba Farid University of Health Sciences, IndiaPanel Discussions
Day 3 August 24, 2016
Independence ASessions:
Bioethics and Quality Regulation | Pharmacokinetics and Pharmacodynamics| Toxicogenomics Challenges and Applications | Pharmacovigilance and Drug Safety
Session Chair: Nicola Stagg, Genentech, USASession Introduction
Title: Gender differences in blood pressure and electrocardiography parameters in response to antihypertensive treatment supplemented with dietary flavonoidsMarina M J Romero-Prado, University of Guadalajara, MexicoTitle: Important considerations for successful Direct-to-Patient study implementationJoe Martinez, Center Point Clinical Services, USATitle: Protective effect of Hypericum triquetrifolium Turra on Cyclophosphamide induced cardiotoxicity in ratSongul Cetik, Mardin Artuklu University, TurkeyTitle: Peripheral neuropathy with microtubule inhibitor containing antibody drug conjugates: Challenges and perspectives in translatability from nonclinical toxicology studies to the clinicNicola Stagg, Genentech, USA
Page 12
Networking and Refreshments @ Foyer
Title: Proposal of supervised data analysis strategy of plasma miRNAs from hybridisation array data with an application to assess hemolysis-related deregulationElena Landoni, University of Milan, ItalyTitle: Clinical research during the Ebola virus disease outbreak in guinea: Lessons learned and ways forwardAbdoul Habib Beavogui, Rural Health of Maferinyah, GuineaTitle: Use of investigative sites in Central & Eastern Europe (CEE) for successful clinical studiesJeffrey Blum, EastHORN Clinical Services, USATitle: Determination of glyceryl trinitrate and its two main metabolites in human plasma using a new sensitive gas chromatography methodMohammadreza Sattari, Tabriz University of Medical Sciences, Iran
Awards & Closing Ceremony
Lunch Break @ Benjamin’s